(G12.9) Spinal muscular atrophy, unspecified

More details coming soon

Icon
701 258 in individuals diagnosis spinal muscular atrophy, unspecified confirmed
Icon
265 837 deaths with diagnosis spinal muscular atrophy, unspecified
Icon
38% mortality rate associated with the disease spinal muscular atrophy, unspecified

Diagnosis spinal muscular atrophy, unspecified is diagnosed Men are 6.83% more likely than Women

374 561

Men receive the diagnosis spinal muscular atrophy, unspecified

129 845 (34.7 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
326 697

Women receive the diagnosis spinal muscular atrophy, unspecified

135 992 (41.6 %)

Died from this diagnosis.

Risk Group for the Disease spinal muscular atrophy, unspecified - Men and Women aged 65-69

Icon
In Men diagnosis is most often set at age 0-94
Icon
Less common in men the disease occurs at Age 95+in in women, the disease manifests at any age
Icon
In Women diagnosis is most often set at age 0-95+

Disease Features spinal muscular atrophy, unspecified

Icon
Absence or low individual and public risk
Icon

Spinal muscular atrophy, unspecified - what does this mean

Spinal muscular atrophy is a genetic disorder that results in the progressive loss of motor neurons in the spinal cord, leading to muscle weakness and atrophy. it is caused by a defect in the survival motor neuron gene, which is responsible for producing a protein that helps motor neurons survive and function properly.

What happens during the disease - spinal muscular atrophy, unspecified

Spinal muscular atrophy (sma) is a progressive genetic disorder caused by the deletion or mutation of the survival motor neuron 1 (smn1) gene. this gene is responsible for producing the survival motor neuron protein, which is essential for the maintenance and function of the lower motor neurons. without this protein, the lower motor neurons degenerate, leading to muscle weakness and atrophy. this can cause a wide range of symptoms, including decreased muscle tone, difficulty with movement, and breathing difficulties.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Physical examination
  • Genetic testing
  • Electromyography (EMG)
  • Magnetic Resonance Imaging (MRI)
  • Nerve conduction velocity (NCV) test
  • Blood tests
  • Urine tests
  • Muscle biopsy

Treatment and Medical Assistance

Main goal of the treatment: To reduce the progression of the disease and improve the patient's quality of life.
  • Prescribing medications to improve muscle function and reduce muscle wasting.
  • Physical therapy to maintain muscle strength and improve mobility.
  • Occupational therapy to help the patient perform daily activities.
  • Speech therapy to help improve communication.
  • Nutritional counseling to ensure the patient is getting the proper nutrition.
  • Assistive devices to help with mobility and communication.
  • Genetic counseling to help patients and families understand the disease.
  • Respiratory therapy to help with breathing problems.
  • Counseling to help with emotional issues.
Icon
28 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Spinal muscular atrophy, unspecified - Prevention

The best way to prevent spinal muscular atrophy, unspecified is to follow a healthy lifestyle, including regular exercise, healthy eating habits, and avoiding smoking and excessive alcohol consumption. additionally, genetic counseling and prenatal testing should be considered for those with a family history of the disease.